Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Salmeterol is a long-acting β2 adrenergic receptor agonist (LABA) used in the treatment and prevention of asthma symptoms and control of chronic obstructive pulmonary disease (COPD) symptoms. Symptoms of bronchospasm include shortness of breath, wheezing, coughing and chest tightness. It is also used to prevent breathing difficulties during exercise…
History, Community, Culture & Applications
Explore the main themes, entities and connections around Salmeterol. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
asthma used inhaled symptoms us use side effects combination β2 also available inhaler mdi beta-2 labas agonist treatment drug action
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Salmeterol | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Salmeterol | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Salmeterol | ATC code | R03AC12 (WHO) | 1.00 | infobox |
| Salmeterol | CAS Number | 89365-50-4 Y | 1.00 | infobox |
| Salmeterol | ChEBI | CHEBI:9011 N | 1.00 | infobox |
| Salmeterol | ChEMBL | ChEMBL1263 N | 1.00 | infobox |
| Salmeterol | ChemSpider | 7987886 Y | 1.00 | infobox |
| Salmeterol | Chirality | Racemic mixture | 1.00 | infobox |
| Salmeterol | CompTox Dashboard (EPA) | DTXSID6023571 | 1.00 | infobox |
| Salmeterol | DrugBank | DB00938 Y | 1.00 | infobox |
| Salmeterol | ECHA InfoCard | 100.122.879 | 1.00 | infobox |
| Salmeterol | Elimination half-life | 5.5 hours | 1.00 | infobox |
| Salmeterol | Formula | C25H37NO4 | 1.00 | infobox |
| Salmeterol | IUPHAR/BPS | 559 | 1.00 | infobox |
| Salmeterol | KEGG | D05792 N | 1.00 | infobox |
| Salmeterol | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Salmeterol | Legal status | CA: ℞-only | 1.00 | infobox |
| Salmeterol | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Salmeterol | Legal status | US: ℞-only | 1.00 | infobox |
| Salmeterol | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Salmeterol | License data | EU EMA: by INN | 1.00 | infobox |
| Salmeterol | License data | US DailyMed: Salmeterol | 1.00 | infobox |
| Salmeterol | Metabolism | Liver (CYP3A4) | 1.00 | infobox |
| Salmeterol | Molar mass | 415.574 g·mol−1 | 1.00 | infobox |
| Salmeterol | PDB ligand | K5Y (PDBe, RCSB PDB) | 1.00 | infobox |
| Salmeterol | Pregnancy category | AU: B3 | 1.00 | infobox |
| Salmeterol | Protein binding | 96% | 1.00 | infobox |
| Salmeterol | PubChem CID | 5152 | 1.00 | infobox |
| Salmeterol | Routes of administration | Respiratory inhalation (Metered-dose inhaler (MDI), Dry-powder inhaler (DPI)) | 1.00 | infobox |
| Salmeterol | Trade names | Serevent, Aeromax, Qitai, Seretide, others | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.